Singapore markets closed

Walvax Biotechnology Co., Ltd. (300142.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.47-0.32 (-2.50%)
At close: 03:04PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
261,527
419,390
728,652
427,748
1,003,187
-
Depreciation & amortisation
-
317,232
264,931
143,837
123,948
-
Change in working capital
-
-193,902
-315,404
-249,022
-908,628
-
Inventory
-
-134,901
-178,789
-390,032
-170,511
-
Other working capital
5,439
188,253
110,314
-398,208
-292,938
-
Other non-cash items
-
18,993
16,859
11,709
9,705
-
Net cash provided by operating activities
-
1,133,769
1,201,491
705,277
114,193
-
Cash flows from investing activities
Investments in property, plant and equipment
-849,536
-945,516
-1,091,177
-1,103,484
-407,131
-
Purchases of investments
-
-10,000
-
-62,462
-407,558
-26,500
Sales/maturities of investments
-
6,784
6,263
109,383
5,219
-
Other investing activities
-
-
-
-1,103,484
-407,131
-351,823
Net cash used for investing activities
-721,012
-807,994
-935,186
-977,150
-730,000
-
Net change in cash
353,032
564,694
365,192
1,464,443
-401,730
-
Cash at beginning of period
3,750,457
3,790,169
3,424,977
1,960,535
2,362,264
-
Cash at end of period
4,100,798
4,354,863
3,790,169
3,424,977
1,960,535
-
Free cash flow
Operating cash flow
-
1,133,769
1,201,491
705,277
114,193
-
Capital expenditure
-849,536
-945,516
-1,091,177
-1,103,484
-407,131
-
Free cash flow
5,439
188,253
110,314
-398,208
-292,938
-